- Vitae tanks after cutting its psoriasis trial short, stoking safety concerns
- Vitae Pharmaceuticals ($VTAE) saw its share value plummet after the company revealed that it enrolled fewer patients than expected in a trial for its oral psoriasis drug, spurring market chatter that the treatment might have a safety problem. The Fort ...
- Historia Docet Historia Vitae Magistra - The Other Side Of History
- Twelve contemporary artists retell and reinvent Indonesian history in the ongoing Historia Docet Historia Vitae Magistra art exhibition at D Gallerie in Jakarta.
- Penn State student-run beer delivery startup Aqua Vitae works to gain traction
- Penn State students are working on creating a beer delivery service in State College. Suresh Rajan, the creator of Aqua Vitae, hopes to launch the student startup later this semester.
- Vitae Pharmaceuticals Inc (VTAE) Stock Rating Lowered by Stifel Nicolaus
- Vitae Pharmaceuticals Inc (NASDAQ:VTAE) was downgraded by investment analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a report issued on Friday, The Fly reports. Vitae Pharmaceuticals (NASDAQ:VTAE) traded down 5.021% during ...
- Vitae Pharmaceuticals Incorporated (NASDAQ:VTAE) Shorted Shares Increased 1.46
- The stock of Vitae Pharmaceuticals Incorporated (NASDAQ:VTAE) registered an increase of 1.46% in short interest. VTAE's total short interest was 1.
Vitae is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Vitae books and related discussion.